Cargando…
Variable expression levels of keratin and vimentin reveal differential EMT status of circulating tumor cells and correlation with clinical characteristics and outcome of patients with metastatic breast cancer
BACKGROUND: CTCs expressing variable levels of epithelial and mesenchymal markers in breast cancer have previously been reported. However, no information exists for keratin expression levels of CTCs in association with disease status, whereas assays for the characterization of transitional EMT pheno...
Autores principales: | Polioudaki, Hara, Agelaki, Sofia, Chiotaki, Rena, Politaki, Eleni, Mavroudis, Dimitris, Matikas, Alexios, Georgoulias, Vassilis, Theodoropoulos, Panayiotis A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4434869/ https://www.ncbi.nlm.nih.gov/pubmed/25962645 http://dx.doi.org/10.1186/s12885-015-1386-7 |
Ejemplares similares
-
Stem cell technology in breast cancer: current status and potential applications
por: Chiotaki, Rena, et al.
Publicado: (2016) -
Epithelial to mesenchymal transition markers expressed in circulating tumour cells of early and metastatic breast cancer patients
por: Kallergi, Galatea, et al.
Publicado: (2011) -
Expression of truncated human epidermal growth factor receptor 2 on circulating tumor cells of breast cancer patients
por: Kallergi, Galatea, et al.
Publicado: (2015) -
Expression of insulin‐like growth factor‐1 receptor in circulating tumor cells of patients with breast cancer is associated with patient outcomes
por: Spiliotaki, Maria, et al.
Publicado: (2017) -
Co-expression of putative stemness and epithelial-to-mesenchymal transition markers on single circulating tumour cells from patients with early and metastatic breast cancer
por: Papadaki, Maria A, et al.
Publicado: (2014)